Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Blueprint Medicines Corporation - Common Stock (NQ:BPMC)

128.55 +0.15 (+0.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,996,550
Open 128.47
Bid (Size) 128.36 (1)
Ask (Size) 130.00 (1)
Prev. Close 128.40
Today's Range 128.35 - 128.58
52wk Range 73.04 - 128.78
Shares Outstanding 63,525,838
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cogent's Chronic Immune Disorder Drug Has Strong Potential To Become A Blockbuster: Analyst
Cogent's bezuclastinib showed strong efficacy in a non-advanced SM trial, with a planned FDA submission expected by the end of 2025. 
Via Benzinga
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
+47.4%
+47.4%
1 Month
+0.5%
+0.5%
3 Month
+56.7%
+56.7%
6 Month
+41.8%
+41.8%
1 Year
+11.5%
+11.5%

More News

Read More
Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Analyst Expectations For Blueprint Medicines's Future
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, SVT, SSBK on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
Unusual volume stocks are being observed in Monday's session.
Via Chartmill
Applied Digital And Riot Platforms Are Among Top 10 Mid-Cap Gainers Last Week (Jun 2-Jun 6): Are The Others In Your Portfolio?
Via Benzinga
Deal Dispatch: TV Stations For Sale, This Buyer Wants Seconds On Pasta
Via Benzinga
Topics Bankruptcy
This Snowflake Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, STR, BPMC, STRM on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BLUEPRINT MEDICINES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Blueprint Medicines Corporation - BPMC
From Kahn Swick & Foti, LLC
Via Business Wire
This ASML Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
Via Benzinga
This Salesforce Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Market Monitor News June 03 (Cleveland-Cliffs, Blueprint Medicines UP - First Solar DOWN)
Via Chartmill
Blueprint Medicines Stock Lands Several Downgrades After Sanofi’s Buyout Deal, But Retail Bulls Keep The Faith
Via Stocktwits
Topics Government
Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Which stocks are gapping on Monday?
Via Chartmill
Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Sanofi To Buy Blueprint Medicines For Up To $9.5B: Retail Sees More Acquisition Offers From European Pharma Companies
Via Stocktwits
These stocks that are showing activity before the opening bell on Monday.
Via Chartmill
Shareholder Alert: The Ademi Firm Investigates Whether Blueprint Medicines Corporation Is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
Sanofi Expands Rare Immunology Portfolio With Blueprint Buyout
Via Benzinga
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BPMC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Blueprint Medicines Corporation Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire

Frequently Asked Questions

Is Blueprint Medicines Corporation - Common Stock publicly traded?
Yes, Blueprint Medicines Corporation - Common Stock is publicly traded.
What exchange does Blueprint Medicines Corporation - Common Stock trade on?
Blueprint Medicines Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Blueprint Medicines Corporation - Common Stock?
The ticker symbol for Blueprint Medicines Corporation - Common Stock is BPMC on the Nasdaq Stock Market
What is the current price of Blueprint Medicines Corporation - Common Stock?
The current price of Blueprint Medicines Corporation - Common Stock is 128.55
When was Blueprint Medicines Corporation - Common Stock last traded?
The last trade of Blueprint Medicines Corporation - Common Stock was at 07/09/25 04:00 PM ET
What is the market capitalization of Blueprint Medicines Corporation - Common Stock?
The market capitalization of Blueprint Medicines Corporation - Common Stock is 8.17B
How many shares of Blueprint Medicines Corporation - Common Stock are outstanding?
Blueprint Medicines Corporation - Common Stock has 8B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.